Lamotrigine in the treatment of SUNCT syndrome

Neurology. 2001 Nov 13;57(9):1723-5. doi: 10.1212/wnl.57.9.1723.

Abstract

Short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is considered an intractable condition. The authors treated five patients with lamotrigine (125 to 200 mg daily), obtaining a complete remission in three patients and a substantial reduction (about 80%) of attack frequency in the other two. No adverse effects were noted.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Analgesics / therapeutic use*
  • Female
  • Headache Disorders / diagnosis
  • Headache Disorders / drug therapy*
  • Humans
  • Lamotrigine
  • Male
  • Middle Aged
  • Triazines / therapeutic use*

Substances

  • Analgesics
  • Triazines
  • Lamotrigine